2172 ⎘
Modified animals Animals modified by administration of exogenous cells
HUMAN SEBACEOUS GLAND CARCINOMA CELL LINE AND US THEREOF
#2Immune Cell-Engrafted Non-Human Animals and Non-Human Animal Models
#3SKIN TISSUE
#4COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE
#5METHOD FOR PRODUCING A SPONTANEOUS METASTASIS MODEL
#6NON-HUMAN ANIMALS COMPRISING A MODIFIED TRANSFERRIN RECEPTOR LOCUS
#7CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#8ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION
#9HUMANIZED IMMUNODEFICIENT MOUSE MODELS
#10IMMUNODEFICIENT NON-HUMAN ANIMALS FOR ASSESSING DRUG METABOLISM AND TOXICITY
#11Genetically Modified Mice and Engraftment
#12METHODS AND MODELS FOR ASSESSING EFFICACY OF IMMUNOTHERAPIES
#13THYMOCYTE HUMANIZED ANIMALS, METHODS OF MAKING AND METHODS OF USE THEREOF
#14AAVR KNOCKOUT MOUSE IN COMBINATION WITH HUMAN LIVER CHIMERISM AND METHODS OF USE AND PRODUCTION OF THE SAME
#15COMPOSITIONS AND METHODS FOR IMPROVED NK CELL THERAPIES
#16MOUSE MODELS OF CYTOKINE RELEASE SYNDROME
#17CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#18METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS
#19VECTORS, GENETICALLY MODIFIED CELLS, AND GENETICALLY MODIFIED NON-HUMAN ANIMALS COMPRISING THE SAME
#20IMMUNODEFICIENT FCGR1 KNOCKOUT MOUSE MODELS
#21METHODS FOR GENERATING FUNCTIONAL HEMATOPOIETIC STEM CELLS
#22HUMANIZED MOUSE MODELS FOR ASSESSING IMMUNE CELL THERAPY
#23GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC NKP46
#24MICRORNA INHIBITOR THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
#25HUMANIZED MOUSE MODEL OF FIBROSIS
#26BRAIN-METASTATIC LUNG CANCER CELL LINE AND USE OF NOGGIN AS MARKER FOR BRAIN METASTASIS OF LUNG CANCER
#27COMMENSAL FUNGUS AND USES THEREOF
#28EFFICIENT DERIVATION OF STABLE PLURIPOTENT BOVINE EMBRYONIC STEM CELLS
#29Humanized M-CSF Mice
#30Genetically Modified Non-Human Animals And Methods Of Use Thereof
#31USE OF ALVEOLAR OR AIRWAY ORGANOIDS FOR THE TREATMENT OF LUNG DISEASES AND DISORDERS
#32Genetically Modified Hepatocyte Populations
#33Kit for breeding a TGEV infection resistant pig and use thereof
#34METHOD FOR PREPARING PLURIPOTENT STEM CELL-DERIVED HEMATOPOIETIC STEM CELL AND METHOD FOR CONSTRUCTING HUMANIZED MOUSE MODEL BY USING HEMATOPOIETIC STEM CELL THUS PREPARED
#35NON-HUMAN ANIMALS HAVING A HUMANIZED B-CELL ACTIVATING FACTOR GENE
#36Non-Human Animals Expressing Humanized CD3 Complex
#37Formation of Three-Dimensional Organ from Pluripotent Stem Cells
#38COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY
#39GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC TFR1
#40ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN NEURONS WITHIN THE THALAMUS
#41HUMAN FIBROLAMELLAR HEPATOCELLULAR CARCINOMAS (hFL-HCCS)
#42NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE
#43COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE
#44Genetically modified non-human having humanized gamma and delta TCR variable genes
#45METHOD FOR CULTURING 3-DIMENSIONAL LUNG CANCER ORGANOID AND METHOD FOR PREPARING PATIENT-DERIVED XENOGRAFT ANIMAL MODEL USING SAME
#46MAINTENANCE OF PROGRAMMED CHRONIC LIVER INJURY OF FAH GENE-DEFICIENT ANIMALS AND APPLICATION THEREOF IN PREPARATION OF HETEROLOGOUS LIVER MODELS
#47DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS
#48IN VITRO METHODS OF DIFFERENTIATING STEM CELLS INTO NEURONS AND NEURONS GENERATED USING THE SAME
#49CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#50MODELS AND METHODS FOR RAPID SCREENING OF THE EFFICACY OF IMMUNOREGULATING DRUGS
#51TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
#52GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO
#53SIMULATION METHOD FOR CHRONIC ATROPHIC GASTRITIS (CAG) LESION AND IDENTIFICATION METHOD FOR MOUSE MODELING
#54INFECTIOUS DISEASE MOUSE MODELS
#55Materials for Tumor Inoculation in Murine Mouse Models and Uses Thereof
#56METHOD OF DETERMINING RESISTANCE TO CHECKPOINT INHIBITOR THERAPIES
#57APPLICATION OF PLURIPOTENT STEM CELLS HAVING MODIFIED DIFFERENTIAL POTENTIAL TO PRODUCING ANIMALS
#58METHOD FOR PRODUCING AVATAR MOUSE AS ATOPIC DERMATITIS ANIMAL MODEL AND USE THEREOF
#59BLADDER ORGANOID AND METHOD FOR PRODUCING SAME
#60GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF
#61METHOD FOR CONSTRUCTING MODEL OF VITILIGO AND THE USE OF THE MODEL
#62HUMANIZED MOUSE MODELS FOR SARS-COV-2 INFECTION
#63GENETICALLY MODIFIED NON-HUMAN ANIMAL EXPRESSING A B2M/FCRN FUSION PROTEIN
#64ENGINEERED CELLS, ANIMAL MODELS, AND USES THEREOF FOR MODELING LOW GRADE GLIOMA (LGG)
#65COMPLEXES FOR GENE DELETION AND EDITING
#66Production of Human Cells, Tissues, and Organs in a Growth Factor Receptor-Deficient Animal Host
#67NON-HUMAN MAMMAL MODEL OF HUMAN DEGENERATIVE DISORDER, USES THEREOF, AND METHOD OF TREATING HUMAN DEGENERATIVE DISORDER
#68ANIMAL MODEL FOR STUDYING CANCER IMMUNOTHERAPY
#69OPTIMIZED CRISPR/CAS9 SYSTEMS AND METHODS FOR GENE EDITING IN STEM CELLS
#70PRIMATIZED RODENT
#71METHOD FOR SEARCHING AND SCREENING FOR TARGET OF ANTI-CANCER AGENT USING NON-HUMAN ANIMAL MODEL HAVING NOG ESTABLISHED CANCER CELL LINE TRANSPLANTED THEREIN
#72MODULATING TLR/NF-KB AND P53 SIGNALING PATHWAYS TO ENHANCE INTERSPECIES CHIMERISM BETWEEN EVOLUTIONARYILY DISTANT SPECIES
#73GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPa/CD47
#74TARGETING GLIOBLASTOMA STEM CELLS THROUGH THE TLX-TET3 AXIS
#75THYMUS ORGANOIDS BIOENGINEERED FROM HUMAN PLURIPOTENT STEM CELLS
#76GENETICALLY MODIFIED NON-HUMAN ANIMALS WITH HUMAN OR CHIMERIC THPO
#77HUMANIZED MOUSE MODEL WITH HUMAN IMMUNE SYSTEM
#78Genetically Modified Non-Human Animals and Methods of Use Thereof
#79METHOD OF MAKING HUMAN MOUSE XENOGRAFTS
#80HUMANIZED TRANSGENIC MOUSE MODEL
#81TRANSGENIC SWINE, METHODS OF MAKING AND USES THEREOF, AND METHODS OF MAKING HUMAN IMMUNE SYSTEM MICE
#82ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF
#83MOSQUITO EGG CRYOPRESERVATION
#84MOUSE MODEL FOR ASSESSING TOXICITIES ASSOCIATED WITH IMMUNOTHERAPIES
#85Rodent Model Of Increased Bone Mineral Density
#86Humanized mouse models for assessing immune cell therapy
#87Method and composition for sorting out of cell comprising a modified gene
#88NON-DISRUPTIVE GENE TARGETING
#89Compositions and methods for producing genetically modified animals
#90ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION
#91METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS
#92Method for integrating biological tissues with a vascular system
#93NON-HLA MATCHED HUMANIZED NSG MOUSE MODEL WITH PATIENT-DERIVED XENOGRAFT
#94NON-HLA MATCHED HUMANIZED NSG MOUSE MODEL WITH PATIENT-DERIVED XENOGRAFT
#95USE OF ECM1 GENE-KNOCKOUT MOUSE IN SCREENING OF ANTI-HEPATIC FIBROSIS DRUG
#96NON-HUMAN ANIMAL MODELS OF SÉZARY SYNDROME
#97METHODS FOR GENERATING FUNCTIONAL HEMATOPOIETIC STEM CELLS
#98Stem cells for wound healing
#99TRANSGENIC PIG ISLETS AND USES THEREOF FOR TREATING DIABETES
#100ANIMAL MODEL FOR AMPLIFYING HUMAN OR ANIMAL CIRCULATING TUMOR CELLS
#101COMPOSITION FOR RECONSTITUTING HUMAN SKIN TISSUE HAVING HAIR FOLLICLES, HUMAN SKIN TISSUE MODEL ANIMAL, AND PRODUCTION METHOD THEREOF
#102Genetically Modified Mice and Engraftment
#103SMALL ANIMAL MODELS FOR IN VIVO TESTING OF POLYOMAVIRUS THERAPEUTICS
#104ISOLATED NASOPHARYNGEAL CARCINOMA CELLS AND DERIVATIVES PREPARED THEREOF
#105RNA-BASED METHODS TO LAUNCH HEPATITIS B VIRUS INFECTION
#106Genetically modified non-human animals and methods of use thereof
#107MODULATION OF ANTIGEN IMMUNOGENICITY BY DELETING EPITOPES RECOGNIZED BY NKT CELLS
#108Non-human animal having human IL-34 and use Thereof
#109USE OF AN EGG GRAFTED WITH TUMOR CELLS IN ORDER TO STUDY THE ANTI-CANCER EFFECTIVENESS OF IMMUNE THERAPIES IN THE ABSENCE OF IMMUNE EFFECTOR CELLS OTHER THAN THOSE IN THE GRAFTED EGG
#110Mouse having a humanized B-cell activating factor gene
#111COMPOSITIONS AND METHODS FOR TREATING A TUMOR SUPPRESSOR DEFICIENT CANCER
#112GENERATION OF A POPULATION OF HINDBRAIN CELLS AND HINDBRAIN-LIKE ORGANOIDS FROM PLURIPOTENT STEM CELLS
#113METHODS AND MATERIALS FOR IMPROVING TRANSPLANT OUTCOMES
#114COMPOSITIONS AND METHODS FOR TREATING A TUMOR SUPPRESSOR DEFICIENT CANCER
#115TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
#116IMMUNODEFICIENT MOUSE
#117Non-human animals having a humanized signal-regulatory protein gene
#118NON-HUMAN VERTEBRATE COMPRISING HUMAN LIVER CELLS TRANSPLANTED THEREIN AND METHOD FOR PRODUCING THE SAME
#119GENERATION OF HUMAN ENDODERMAL ORGANS IN PIG MODEL USING LINEAGE RESTRICTED ENDODERMAL PRECURSORS
#120NON-DISRUPTIVE GENE TARGETING
#121NON-HUMAN ANIMALS HAVING A HUMANIZED A PROLIFERATION-INDUCING LIGAND GENE
#122Mouse having a humanized cluster of differentiation 47 gene
#123Humanized Mouse Model
#124SINGLE LUNG CELL-DERIVED ORGANOIDS
#125Single kidney cell-derived organoids
#126Genetic modification of rats
#127Method for culturing 3-dimensional lung cancer organoid and method for preparing patient-derived xenograft animal model using same
#128Humanized M-CSF mice
#129Production of fertile XY female animals by silencing of genes on the Y chromosome
#130IMMUNODEFICIENT NON-HUMAN ANIMAL
#131Non-human animals expressing humanized CD3 complex
#132NOVEL IMMUNODEFICIENT RAT FOR MODELING HUMAN CANCER
#133PRODUCTION AND USE OF RED BLOOD CELLS
#134Method for preparing a large animal model with peritoneal carcinomatosis
#135METHOD FOR GENERATING ANTIBODIES WITH IMPROVED SPECIFICITY AND/OR AFFINITY
#136Use of alveolar or airway organoids for the treatment of lung diseases and disorders
#137Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
#138Molecular imaging method for evaluating liver regeneration capacity after ALPPS operation
#139EFFICIENT DERIVATION OF STABLE PLURIPOTENT BOVINE EMBRYONIC STEM CELLS
#140Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
#141In vitro methods of differentiating stem cells into neurons and neurons generated using the same
#142Method for producing chimeric animal
#143NON-HUMAN ANIMAL AND METHOD FOR PRODUCING SAME
#144HLA G-MODIFIED CELLS AND METHODS
#145TARGETING GLIOBLASTOMA STEM CELLS THROUGH THE TLX-TET3 AXIS
#146Methods of Generating Mature Human Muscle Fibers
#147MicroRNA inhibitor therapy in systemic lupus erythematosus
#148Non-human animals expressing humanized CD3 complex
#149GENERATION AND CORRECTION OF A HUMANIZED MOUSE MODEL WITH A DELETION OF DYSTROPHIN EXON 44
#150METHODS AND COMPOSITIONS FOR ALLEVIATING CYTOKINE RELEASE SYNDROME
#151Construct having structure and cell mass linked together
#152Methods and materials for producing T cells
#153IMMUNODEFICIENT MICE EXPRESSING HUMAN INTERLEUKIN 15
#154Chimeric mouse comprising stably transplanted bat cells
#155Genetically modified non-human animals and methods of use thereof
#156Avian induced pluripotent stem cells and their use
#157Non-human animals having a humanized signal-regulatory protein gene
#158Methods for cancer treatment
#159PERSONALIZED ANTI-CANCER AGENT SCREENING SYSTEM
#160Genetically modified non-human animals and methods of use thereof
#161NSG mice lacking MHC class I and class II
#162Genetically modified non-human animals expressing human EPO
#163HLA G-modified cells and methods
#164Transplantation method to increase the establishment rate of human tumors in immunodeficient mice
#165Rat model of down syndrome and method for producing same
#166ANIMAL MODEL SYSTEM AND USES THEREOF
#167ENGINEERING OF HUMANIZED CAR T-CELL AND PLATELETS BY GENETIC COMPLEMENTATION
#168Cell and utilization thereof
#169Anti-NRP1 antibody screening method
#170Method for Determining the Effectiveness of Treatment for the Prevention of Heartworm Disease
#171Fumarylacetoacetate hydrolase (FAH)-deficient and immunodeficient rats and uses thereof
#172Methods of engineering human induced pluripotent stem cells to produce liver tissue
#173TUMOR CELL XENOGRAFT MODEL IN ZEBRAFISH, AND METHODS OF CONSTRUCTING AND USING THE SAME
#174Genetically modified mouse comprising a chimeric TIGIT
#175HYBRID NUCLEIC ACID MOLECULES AND THEIR USE
#176Urokinase-type plasminogen activator transgenic mouse
#177Genetically modified non-human animal with human or chimeric TIGIT
#178HUMANIZED MOUSE MODEL WITH IMPROVED HUMAN INNATE IMMUNE CELL DEVELOPMENT
#179Immunodeficient non-human animal
#180Complexes for gene deletion and editing
#181Genetic modification of rats
#182Three Dimensional Bioprinted Tumor Models for Drug Testing
#183Genetically modified mice and engraftment
#184Methods and materials for using butyrylcholinesterases to treat cancer
#185Engineering of Humanized Kidney by Genetic Complementation
#186Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity
#187Vaccine comprising drug and parasite administration
#188Organoid with metastatic property and use thereof
#189METHOD OF CONSTRUCTING HUMANIZED MURINE MODEL OF CHRONIC VIRAL HEPATITIS USING STEM CELL
#190METHODS AND COMPOSITIONS RELATING TO IMPROVED HUMAN RED BLOOD CELL SURVIVAL IN GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMALS
#191Methods for generating functional hematopoietic stem cells
#192Human fibrolamellar hepatocellular carcinomas (hFL-HCCs)
#193Compositions and methods of cellular immunotherapy
#194STEM CELLS FOR MODELING TYPE 2 DIABETES
#195Adeno-associated virus compositions for restoring HBB gene function and methods of use thereof
#196ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION
#197Non-human animals having a humanized B-cell activating factor gene
#198Non-human animals having a humanized signal-regulatory protein gene
#199High-affinity anti-human folate receptor beta antibodies and methods of use
#200Oncogenic Models Based on Delivery and Use of the CRISPR-Cas Systems, Vectors and Compositions
#201Genetically modified non-human animals and methods of use thereof
#202Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
#203Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
#204Targeting glioblastoma stem cells through the TLX-TET3 axis
#205EFFICIENT, SCALABLE PATIENT-DERIVED XENOGRAFT SYSTEM BASED ON A CHICK CHORIOALLANTOIC MEMBRANE (CAM) IN VIVO MODEL
#206Multimodal trail molecules expressed in T cells
#207HUMANIZED MOUSE MODEL
#208Compositions and methods for enhanced genome editing
#209HUMANIZED MOUSE MODEL OF MYASTHENIA GRAVIS AND MSC THERAPY
#210Animal study model for cancer
#211Method for producing chimeric animal
#212Compositions for use in recovering or ameliorating deterioration of physiological functions due to aging
#213Mode of inducing renal transplant rejection on animals and its manufacturing approach
#214USE OF MAPK INHIBITORS TO REDUCE LOSS OF HEMATOPOIETIC STEM CELLS DURING EX VIVO CULTURE AND/OR GENETIC MANIPULATION
#215High-throughput mouse model for optimizing antibody affinities
#216Genetically modified non-human animals and methods of use thereof
#217Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients
#218Preclinical model of neonatal necrotizing enterocolitis
#219Method for Evaluating Hematological Toxicity of Drug Under Evaluation, and Model for Evaluating Hematological Toxicity of Drug Under Evaluation
#220Method for measuring tumor burden in patient derived xenograft (PDX) mice
#221Optimized CRISPR/cas9 systems and methods for gene editing in stem cells
#222GENERATION OF HUMAN MACROPHAGES IN IMMUNODEFICIENT NON-HUMAN HOSTS
#223Method for generating a humanized transgenic mouse comprising a human APRIL gene
#224Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44
#225Mouse lymphoma cell line and animal model of human high grade B-cell lymphoma
#226Delivery, use and therapeutic applications of the CRISPR-cas systems and compositions for modeling mutations in leukocytes
#227Method of using mouse having a humanized cluster of differentiation 47 gene
#228Immunity enhancing agent for cancer by Allergin-1 antagonist
#229PERSONALIZED TREATMENT OF DISEASES AND DISORDERS
#230Methods and materials for producing T cells
#231PROCESS FOR INDUCING RESISTANCE TO DIPHTHERIA TOXIN IN HUMAN CELLS, PRODUCTS AND USES THEREOF
#232Human IL-15-secreting immunodeficient mouse
#233Induced extended pluripotent stem cells, method of making and using
#234Non-human animal having human CD3 gene substituted for endogenous CD3 gene
#235Non-HLA matched humanized NSG mouse model with patient-derived xenograft
#236Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
#237Production and use of red blood cells
#238Method for producing blood chimeric animal
#239Transgenic Immunodeficient Mouse Expressing Human SIRP-alpha
#240HUMANIZED MICE AND USES THEREOF
#241Non-human animals having a humanized signal-regulatory protein gene
#242Method for producing non-human large mammal or fish each capable of producing gamete originated from different individual
#243Host cells with artificial endosymbionts
#244METHODS AND COMPOSITIONS RELATING TO AN EMBRYONIC STEM CELL-BASED TUMOR MODEL
#245Genetically Modified Non-Human Animals And Methods Of Use Thereof
#246Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells
#247In vivo methods for identifying cancer-associated immunotherapy targets
#248METHODS FOR BREAKING IMMUNOLOGICAL TOLERANCE USING MULTIPLE GUIDE RNAS
#249DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS
#250Method for reestablishment of pluripotent stem cells
#251Method for producing antigen-specific B cells and their use for the production of hybridoma cells and monoclonal antibodies
#252Methods and compositions for generating a mouse
#253HLA G-modified cells and methods
#254Humanized M-CSF mice
#255Methods for establishing animal model of hepatocellular carcinoma bone metastasis
#256INDUCED PLURIPOTENT STEM CELLS
#257Three-Dimensional Hydrogels that Support Growth of Physiologically Relevant Tissue and Methods of Use Thereof
#258Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled 1, Frizzled 2 or Frizzled 7 extracellular cysteine-rich domain
#259Non-human animals having a humanized signal-regulatory protein gene
#260METHOD FOR PRODUCING ANIMAL MODEL OF OSTEOBLASTIC BONE METASTASIS
#261Telomerase reverse transcriptase-based therapies
#262Production of fertile XY female mice from XY mouse ES cells
#263Animal models, cell lines and methods for screening hepatitis C virus vaccines
#264Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo
#265Stem cells for wound healing
#266Single cell-derived organoids
#267TGFß SIGNALING INDEPENDENT NAÏVE INDUCED PLURIPOTENT STEM CELLS, METHODS OF MAKING AND USE
#268Transgenic pig islets and uses thereof for treating diabetes
#269Non-human animals having a humanized B-cell activating factor gene
#270Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#271Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#272Genetically modified mice and engraftment
#273NON-HUMAN ANIMALS EXPRESSING HUMANIZED CD3 COMPLEX
#274METHOD FOR PRODUCING TISSUE AND ORGAN
#275ANIMAL MODEL FOR STUDYING NEUROBLASTOMAS
#276ENGINEERING OF HUMANIZED CAR T-CELL AND PLATELETS BY GENETIC COMPLEMENTATION
#277HUMANIZED MOUSE MODELS AND USES THEREOF
#278METHODS INVOLVING MACROPHAGE TUMOR CELL FUSION HYBRIDS
#279METHOD OF GENERATING STERILE TERMINAL SIRES IN LIVESTOCK AND ANIMALS PRODUCED THEREBY
#280Production of fertile XY female animals by silencing of genes on the Y chromosome
#281Rodent model of prostate cancer
#282Mouse model of hyperuricemia
#283Genetic modification of rats
#284Human SIRPα transgenic mice and their methods of use
#285VH4 ANTIBODIES AGAINST GRAY MATTER NEURON AND ASTROCYTE
#286Non-human animals having a humanized signal-regulatory protein gene
#287High-throughput mouse model for optimizing antibody affinities
#288Feeder-free method for culture of bovine and porcine spermatogonial stem cells
#289COMPOSITIONS AND METHODS FOR PRODUCING GENETICALLY MODIFIED ANIMALS
#290Animal model of nash-induced hepatocellular carcinoma and methods for developing specific therapeutics
#291Method for selectively inhibiting ACAT1 in the treatment of obesity, metabolic syndrome, and atherosclerosis
#292NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE
#293Genetically modified non-human animals and methods relating to innate immune system response detection
#294Non-human animals having a disruption in a C9ORF72 locus
#295Population of isolated chicken cells reprogrammed from somatic cells
#296Biodegradable matrix comprising stem cells that express soluble TRAIL
#297ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION
#298Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#299Methods and compositions for generating a mouse
#300ES Cell-Derived Mice From Diploid Host Embryo Injection